Caffeine reverses antinociception by amitriptyline in wild type mice but not in those lacking adenosine A1 receptors

Neuroscience Letters

Volumn 440, Issue 2, 2008, Pages 181-184

  Sawynok, Jana ^a   Reid, Allison R ^a   Fredholm, Bertil B ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adenosine A1 receptors; Amitriptyline; Antinociception; Caffeine

Indexed keywords

ADENOSINE A1 RECEPTOR; AMITRIPTYLINE; CAFFEINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; FEMALE; MALE; MOUSE; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL;

AMITRIPTYLINE; ANALGESICS, NON-NARCOTIC; ANIMALS; BEHAVIOR, ANIMAL; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; GENOTYPE; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RECEPTOR, ADENOSINE A1;

EID: 45449095443     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.05.074     Document Type: Article

References (27)

1. Abo-Salem O.M., Hayallah A.M., Bilkei-Gorzo A., Filipek B., Zimmer A., and Müller C. Antinociceptive effects of novel A2B adenosine receptor antagonists. J. Pharmacol. Exp. Ther. 308 (2004) 358-366
2. Aley K.O., and Levine J.D. Multiple receptors involved in peripheral α2, μ, and A1 antinociception, tolerance, and withdrawal. J. Neurosci. 17 (1997) 735-744
3. Esser M.J., and Sawynok J. Caffeine blockade of the thermal anti-hyperalgesic effect of acute amitriptyline in a rat model of neuropathic pain. Eur. J. Pharmacol. 399 (2001) 131-139
4. Esser M.J., Chase T., Allen G.V., and Sawynok J. Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions. Eur. J. Pharmacol. 430 (2001) 211-218
5. Finnerup N.B., Otto M., McQuay H.J., Jensen T.S., and Sindrup S.H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118 (2005) 289-305
6. Fredholm B.B., Bättig K., Holmén J., Nehlig A., and Zvartau E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51 (1999) 83-133
7. Fredholm B.B., Chen Y., Franco R., and Sitkovsky M. Aspects of the general biology of adenosine A2A signaling. Prog. Neurobiol. 83 (2007) 263-276
8. Fredholm B.B., Chen J.-F., Masino S.A., and Vaugeois J.-M. Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 385-412
9. 1, receptors mediate the arousal effect of caffeine. Nat. Neurosci. 8 (2005) 858-859
10. Hussey M.J., Clarke G.D., Ledent C., Hourani S.M.O., and Kitchen I. Reduced response to the formalin test and lowered spinal NMDA glutamate receptor binding in adenosine A2A receptor knockout mice. Pain 129 (2007) 287-294
11. Johansson B., Halldner L., Dunwiddie T.V., Masino S.A., Poelchen W., Giménez-Llort L., Escorihuela R.M., Fernández A., Wiesenfeld-Hallin Z., Xu X.-J., Hardemark A., Herlenius E., and Fredholm B.B. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9407-9412
12. Ledent C., Vaugeois J.M., Shiffmann S.N., Pedrazzini T., El Yacoubini M., Vanderhaeghen J.J., Costentin J., Heath J.K., Vassert G., and Parmentier M. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2A receptor. Nature 388 (1997) 647-678
13. Micó J.A., Ardid D., Berrocosco E., and Eschalier A. Antidepressants and pain. Trends Pharmacol. Sci. 27 (2006) 348-354
14. Pareek S.S., Chopde C.T., and Thakur Desai P.A. Adenosine enhances (the) analgesic effect of tricyclic antidepressants. Ind. J. Pharmacol. 26 (1994) 159-161
15. Phillis J., and Wu P.H. The effect of various centrally active drugs on adenosine uptake by the central nervous system. Comp. Biochem. Pharmacol. 72C (1982) 179-187
16. Sawynok J. Adenosine receptor activation and nociception. Eur. J. Pharmacol. 347 (1998) 1-11
17. Sawynok J., and Liu X.J. Adenosine in the spinal cord and periphery, release and regulation of pain. Prog. Neurobiol. 69 (2003) 313-340
18. Sawynok J., and Reid A.R. Caffeine analgesia in the formalin test: role of formalin concentration and adenosine A1 and A2 receptors. Eur. J. Pharmacol. 298 (1996) 105-111
19. Sawynok J., and Reid A.R. Antinociception by tricyclic antidepressants in the rat formalin test. Differential effects on different behaviours following systemic and spinal administration. Pain 93 (2001) 51-59
20. Sawynok J., Reid A.R., and Esser M.J. Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine. Pain 80 (1999) 45-55
21. Sawynok J., Reid A.R., Liu X.J., and Parkinson F.E. Amitriptyline enhances extracellular levels of adenosine in the rat hindpaw and inhibits adenosine uptake. Eur. J. Pharmacol. 518 (2005) 116-122
22. Sawynok J., and Yaksh Y.L. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol. Rev. 45 (1993) 43-85
23. Ulugol A., Karadag H.C., Tamer M., Firat Z., Aslantas A., and Dokmeci I. Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats. Neurosci. Lett. 328 (2002) 129-132
24. Wang Y.-W., Bowersox S.S., Pettus M., and Gao D. Antinociceptive properties of fenfluramine, a serotonin reuptake inhibitor, in a rat model of neuropathy. J. Pharmacol. Exp. Ther. 291 (1999) 1008-1016
25. Wu W.P., Hao J.X., Fredholm B.B., Weisenfeld-Hallin Z., and Xu X.J. Effect of acute and chronic administration of caffeine on pain-like behaviors in rats with partial sciatic nerve injury. Neurosci. Lett. 402 (2006) 164-166
26. Wu W.P., Hao J.-X., Halldner L., Lövdahl C., DeLander G.E., Wiesenfeld-Hallin Z., Fredholm B.B., and Xu X.-J. Increased nociceptive response in mice lacking the adenosine A1 receptor. Pain 113 (2005) 395-404
27. Wu W.P., Hao J.X., Halldner-Henriksson L., Xu X.J., Jacobson M.A., Wiesenfeld-Hallin Z., and Fredholm B.B. Decreased inflammatory pain due to reduced carrageenan-induced inflammation in mice lacking adenosine A3 receptors. Neuroscience 114 (2002) 523-527